

Course Description
Inflammatory breast cancer (IBC) is a relatively rare but aggressive form of breast cancer that is characterized by breast redness and swelling, skin thickening, and the lack of a well-defined palpable mass. Patients with IBC are more likely than those with other types of breast cancer to have metastatic disease at the time of diagnosis, and the long-term prognosis for these patients is poor. The early recognition of IBC is often challenging and treatment guidelines have only recently described IBC as a distinct clinical entity with its own treatment algorithm. There are no specific molecular or genetic characteristics that distinguish IBC from other types of breast cancer, and the diagnosis depends on clinical and histological evaluation. Imaging is a critical part of the workup of suspected IBC. Mammography is usually the preferred imaging modality for examining patients with suspected IBC. Sonography is especially useful in fine needle guided biopsy and examining the lymph nodes. Although not recommended as a first-line approach for evaluation of suspected IBC, magnetic resonance imaging provides high spatial resolution, and the addition of intravenous contrast may permit visualization of changes that are not evident with mammography or ultrasonography. Positron-emission tomography/computed tomography is a newer technique that is increasingly being used to evaluate patients with IBC. It is especially useful for examining lymph nodes and distant metastasis. This article discusses the diagnosis and treatment of IBC, which depends on a multimodal approach that requires the close cooperation of medical professionals from several specialties, including medical and radiation oncology, surgery, radiology, and pathology. Various imaging techniques are described, along with the typical imaging findings and the strengths and limitations of each imaging method.
Learning Objectives
After reading this article, the participant should be able to:
Categories: Mammography, Nuclear Medicine, Radiation Therapy/Dosimetry

CE Information
In order to receive CE credit, you must first complete the activity content. When completed, go to the "Take CE Test!" link to access the post-test.
Submit the completed answers to determine if you have passed the post-test assessment. You must obtain a score of 75% to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test.
Participants successfully completing the activity content and passing the post-test will receive 1.0 ARRT Category A credits.
Approved by the American Society of Radiologic Technologists for ARRT Category A credit.
Approved by the Medical Dosimetrist Certification Board for MDCB credit.
This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same or any subsequent biennium.

| Category | Content Area | Credits |
|---|---|---|
| Breast Sonography | Patient Care | 0.5 |
| Breast Sonography | Procedures | 0.25 |
| Magnetic Resonance | Patient Care | 0.5 |
| Magnetic Resonance | Procedures | 0.25 |
| Mammography | Patient Care | 0.25 |
| Mammography | Procedures | 0.75 |
| Nuclear Medicine | Patient Care | 0.5 |
| Nuclear Medicine | Procedures | 0.25 |
| PTH | Procedures | 0.25 |
| Radiation Therapy | Patient Care | 0.5 |
| Radiation Therapy | Procedures | 0.5 |
| Radiologist Assistant | Procedures | 1 |
| Sonography | Patient Care | 0.5 |
| Sonography | Procedures | 0.25 |

| Category | Subcategory | Credits |
|---|---|---|
| Breast Sonography | Pathology | 0.25 |
| Breast Sonography | Patient Interactions and Management | 0.5 |
| Magnetic Resonance | Body | 0.25 |
| Magnetic Resonance | Patient Interactions and Management | 0.5 |
| Mammography | Anatomy, Physiology and Pathology | 0.25 |
| Mammography | Mammographic Positioning and Procedures | 0.5 |
| Mammography | Patient Interactions and Management | 0.25 |
| Nuclear Medicine | Endocrine and Oncology Procedures | 0.25 |
| Nuclear Medicine | Patient Interactions and Management | 0.5 |
| PTH | Treatment Sites | 0.25 |
| Radiation Therapy | Patient and Medical Record Management | 0.5 |
| Radiation Therapy | Treatment Sites and Tumors | 0.25 |
| Radiation Therapy | Treatments | 0.25 |
| Radiologist Assistant | Thoracic Section | 1 |
| Sonography | Patient Interactions and Management | 0.5 |
| Sonography | Superficial Structures and Other Sonographic Procedures | 0.25 |

| Category | Credits |
|---|---|
| Digital | 0.25 |
| Fluoroscopy | 0 |
| Mammography | 1 |
Mark P. Bowes, PhD
*Medical Writer, Portland, Oregon.
Address correspondence to: Mark P. Bowes, PhD, Medical Writer, 7135 SE 18th Avenue, Portland, OR 97202. E-mail: mpbowes@gmail.com.
Disclosure Statement: Dr Bowes reports having no financial or advisory relationships with corporate organizations related to this activity.
ABSTRACT
Inflammatory breast cancer (IBC) is a relatively rare but aggressive form of breast cancer that is characterized by breast redness and swelling, skin thickening, and the lack of a well-defined palpable mass. Patients with IBC are more likely than those with other types of breast cancer to have metastatic disease at the time of diagnosis, and the long-term prognosis for these patients is poor. The early recognition of IBC is often challenging and treatment guidelines have only recently described IBC as a distinct clinical entity with its own treatment algorithm. There are no specific molecular or genetic characteristics that distinguish IBC from other types of breast cancer, and the diagnosis depends on clinical and histological evaluation. Imaging is a critical part of the workup of suspected IBC. Mammography is usually the preferred imaging modality for examining patients with suspected IBC. Sonography is especially useful in fine needle guided biopsy and examining the lymph nodes. Although not recommended as a first-line approach for evaluation of suspected IBC, magnetic resonance imaging provides high spatial resolution, and the addition of intravenous contrast may permit visualization of changes that are not evident with mammography or ultrasonography. Positron-emission tomography/computed tomography is a newer technique that is increasingly being used to evaluate patients with IBC. It is especially useful for examining lymph nodes and distant metastasis. This article discusses the diagnosis and treatment of IBC, which depends on a multimodal approach that requires the close cooperation of medical professionals from several specialties, including medical and radiation oncology, surgery, radiology, and pathology. Various imaging techniques are described, along with the typical imaging findings and the strengths and limitations of each imaging method.
* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.
Enter your email address to receive our new course alerts.